Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Goodwin shares jump on major submarine partnership

(Sharecast News) - Goodwin's stock price surged on Wednesday after the engineering conglomerate reported a big increase in activity and announced a "major" collaboration agreement with US defence group Northrop Grumman International Trading Inc. (NGIT). The partnership covers four key defence programmes, starting with an initial $16m order. However, as US submarine programmes have funding releases, expected orders through the agreement will "likely" develop to over $200m.

NGIT has also signed an exclusivity agreement which will see Goodwin's Steel Castings division serve as the sole supplier for a critical programme component which would account for approximately 25-30% of the total deal value.

"This collaboration strengthens the Group's position in core defence sectors and reflects our growing reputation as a trusted partner in delivering technically advanced components for mission-critical applications. The Board believes this partnership will create further opportunities for collaboration on future defence programmes," the company said.

Goodwin also announced in a trading update that its workload totalled £357m by 31 August, up 24% from April, which was being matched by a similar increase in levels of activity.

Shares were 16.3% higher at 12,961.74p before the close of play.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.